Citação norma APA

Baig, N. A., Taylor, R. P., Lindorfer, M. A., Church, A. K., LaPlant, B. R., Pavey, E. S., . . . Zent, C. S. (2012). Complement dependent cytotoxicity (CDC) in chronic lymphocytic leukemia (CLL): Ofatumumab enhances alemtuzumab CDC and reveals cells resistant to activated complement. Leuk Lymphoma.

Citação norma Chicago

Baig, Nisar A., Ronald P. Taylor, Margaret A. Lindorfer, Amy K. Church, Betsy R. LaPlant, Emily S. Pavey, Grzegorz S. Nowakowski, and Clive S. Zent. "Complement Dependent Cytotoxicity (CDC) in Chronic Lymphocytic Leukemia (CLL): Ofatumumab Enhances Alemtuzumab CDC and Reveals Cells Resistant to Activated Complement." Leuk Lymphoma 2012.

Citação norma MLA

Baig, Nisar A., et al. "Complement Dependent Cytotoxicity (CDC) in Chronic Lymphocytic Leukemia (CLL): Ofatumumab Enhances Alemtuzumab CDC and Reveals Cells Resistant to Activated Complement." Leuk Lymphoma 2012.

Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.